Anti-amyloid trials raise scientific and ethical questions
Ackley and colleagues found that lowering brain β-amyloid levels in Alzheimer’s disease had no significant effect on cognition in 14 clinical trials on a total of 4596 patients.1 After a significant…
Read Original Article: Anti-amyloid trials raise scientific and ethical questions »
